illumina competitors 2019

Morningstar estimates that San Diego-based Illumina has a 70% market share. Illumina leverages AWS … Thursday, November 21, 2019. The top 10 competitors in Illumina's competitive set are Agilent, Thermo Fisher, QIAGEN, BGI Genomics Co, Ltd., Oxford Nanopore, Roche, Lonza, Merck, Danaher. Over the last four quarters, Illumina's revenue has decreased by 16.6%. Desktop. Dimensions. SAN DIEGO--(BUSINESS WIRE)--Jul. Illumina Inc s' competitors and its Market Share by segment - CSIMarket At that price, and also the accompanying speed at which the DNA sequencing can be done, emergency illnesses can be immediately diagnosed. As another way to dig a competitive moat, Illumina last fall agreed to buy smaller competitor Pacific Biosciences for $1.2 billion. Illumina Remains NGS Leader But Competitors Expected to Gain, Survey Finds. The CMA’s investigation has found that PacBio is one of Illumina’s closest competitors and vice versa. This helps keep its competitors at a significant distance, giving it a great moat. [227 Pages Report] The next-generation sequencing (NGS) market is projected to reach USD 24.4 billion by 2025 from USD 7.8 billion in 2019, at a CAGR of 20.9%., at a CAGR of 20.9%. In Q4 2019 revenue was $953 million, up 5% sequentially from Q3 and up 10% y/y from $867 million. As NGS testing begins to play a more significant role in patient care, Illumina is committed to providing clinical solutions, both Illumina developed and partner driven, that support the diagnosis and management of human diseases. • List of ILMN Competitors With net margin of 22.54 % company reported lower profitability than its competitors. More importantly, the free cash flow yield value for Illumina stock is 1.7%. View the latest Illumina Inc. (ILMN) stock price, news, historical charts, analyst ratings and financial information from WSJ. Jan 05, 2018 | Julia Karow. San Diego-based Illumina, the world’s largest DNA sequencing company, powers everything from direct-to consumer tests to livestock breeding. Nov 13, 2019 | staff reporter. Illumina Inc (ILMN) - Product Pipeline Analysis, 2019 Update Summary Illumina Inc (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of - Market research report and industry analysis - 12493065 Illumina sequencing and array technologies fuel advancements in life science research, translational and consumer genomics, and molecular diagnostics. Device. The British CMA is blocking the merging of @illumina and @PacificBio not to keep the market competitive, but to eliminate Picific Bio so the British company Nanopore will dominate the long sequencing field. Competition. The market values Illumina stock’s net income at over 42 times. Illumina. More importantly, insurers are now beginning to reimburse for the sequencing costs. https://www.genengnews.com/a-lists/top-10-sequencing-companies-2 Oct 15, 2019 to Nov 06, 2019 Illumina. Illumina is thought to have a worldwide next-generation sequencing market share of around 70%, and was boosted recently by Qiagen quitting the sequencing space (Storm-tossed Qiagen plots a course to higher growth, October 8, 2019). Comparing the results to its competitors, Illumina Inc reported Total Revenue decrease in the 3 quarter 2020 year on year by -12.46 %, faster than overall decrease of Illumina Inc 's competitors by -12.46 %, recorded in the same quarter. And on that note, ILMN stock’s P/E ratio is also sky high. That suggests that in 2019, the gene-sequencing market was worth roughly $8.9bn, and given Illumina's revenues in 2019 were $3.54bn, the company's share of the total market was ~40%. The Guide focuses on high total yield value stocks, which includes both dividend and buyback yields. Oct 09, 2019 to Nov 10, 2019 Illumina. “Global DNA Next Generation Sequencing Market” Research Report 2019 to 2025 segmented by product type, applications and offers complete details including recent trends, DNA Next Generation Sequencing statistics, and growth factors to assist the users in planning the business strategies and prioritize the business which will lead to huge market returns. On July 11 th, Illumina announced preliminary revenue for Q2 2019 and updated 2019 revenue guidance. 1125 N. Charles St, Baltimore, MD 21201. Oct 15, 2019 to Nov 06, 2019 Illumina. Copyright © That means it will take an investor 58.8 years to recoup his investment if free cash flow does not grow. Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. Published 24 October 2019 Brexit. Here is what that means. Auditor's conclusion. Wired magazine recently published a very interesting story about Illumina. 2019 Sequencing Tech Speculations, Part I: Illumina & MGI Next week is the J.P. Morgan Healthcare Conference. Nearly one year after DNA sequencing machine maker Illumina announced plans to acquire smaller rival Pacific Biosciences, antitrust regulators in the UK say the merger could stifle competition … Please reach out to our Investor Relations team at ir@illumina.com if you have questions. Device. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. In addition, subscribers a two-week free trial. As of this writing, Mark Hake, CFA does not hold a position in any of the aforementioned securities. Check how the new Brexit rules affect you. Oct 09, 2019 to Nov 10, 2019 Illumina. Illumina has become dominant in the field of next-generation DNA sequencing by building machines that sequenced DNA more cheaply and rapidly than several competitors, many of … 3: A has-been … Specifically, in Q3 2020's revenue was $794M; in Q2 2020, it was $633M; in Q1 2020, it was $859M; in Q4 2019, Illumina's revenue was $952M. 300x250. ... Illumina Alternatives & Competitors Illumina, Inc. At Illumina, our goal is to apply innovative technologies and revol... (1 contacts listed) The Illumina Accelerator Sequencing Grant Competition encourages entrepreneurs to build startups using next-generation sequencing. The top 10 competitors average 9.3B. However, Illumina appears to … The company now expects to report Q2 revenue of … Comparing the results to its competitors, Illumina Inc reported Total Revenue decrease in the 3 quarter 2020 year on year by -12.46 %, faster than overall decrease of Illumina Inc 's competitors by -12.46 %, recorded in the same quarter. Illumina's revenue is the ranked 7th among it's top 10 competitors. • List of ILMN Competitors With net margin of 22.54 % company reported lower profitability than its competitors. Revenue ($ millions) $794. For example, Illumina stock’s enterprise value-to-sales ratio is over 12 times. But I have already shown that net income only grew 5%. However, Illumina currently holds more than 80% of the sequencing market, leaving only crumbs to its competitors. Cloudflare Ray ID: 6165907dccaa9cfa Partnership to accelerate the adoption of next-generation sequencing (NGS) in clinical decision-making Illumina, Inc. (NASDAQ: ILMN) and QIAGEN N.V. (NYSE: QGEN) (Frankfurt Prime Standard: QIA) today announced a 15-year partnership intended to broaden the availability and use of NGS-based IVD kits, including companion diagnostics, for patient management. More importantly, Illumina’s free cash flow fell 4.4% year-over-year to $218 million. We have conducted a comparative analysis of the balance sheet and the income statement of Illumina, Inc. (hereafter – the "Company") for the year 2019 submitted to the U.S. Securities and Exchange Commission (SEC). ET by MarketWatch Automation PerkinElmer Inc. stock falls Tuesday, underperforms market We have conducted a comparative analysis of the balance sheet and the income statement of Illumina, Inc. (hereafter – the "Company") for the year 2019 submitted to the U.S. Securities and Exchange Commission (SEC). The article really opens your eyes to the practical aspects of what DNA sequencing is all about. The competition: Who is Illumina’s new $100M startup, Grail, up against in cancer liquid biopsy screening? Earnings for Illumina are expected to grow by 19.13% in the coming year, from $4.39 to $5.23 per share. illumina is the top-ranking maker of next-generation sequencing tools used by life sciences and drug researchers to isolate and analyze genes. Please enable Cookies and reload the page. Jan. 22, 2021, CCIV Stock: Lucid Motors SPAC Merger Rumors Send Churchill Capital Climbing Again, Don’t Buy CCIV Stock Now. But you pay a very high price for that security. It discusses how Illumina helped the parents of a young child with a rare and undiagnosed disease. Illumina, Inc. Auditor's conclusion. U.S. antitrust enforcers moved to block the merger of two DNA-sequencing firms -- Illumina Inc. and Pacific Biosciences of California Inc. -- saying the deal would harm competition. This article has been updated from a previous version to clarify that Illumina, not PacBio, is proposing the remedy to the UK Competition and Markets Authority. Copyright © 2021 InvestorPlace Media, LLC. See insights on Illumina including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. However, Illumina appears to capture the bulk of sales in the industry. The top ten competitors in the market made up to 49.8% of the total market in 2019. • ... Illumina Alternatives & Competitors Illumina, Inc. At Illumina, our goal is to apply innovative technologies and revol... (1 contacts listed) That ratio should is so high it could be a typical price-to-earnings ratio. It isn’t going anywhere. Britain's competition watchdog said on Tuesday the planned $1.2 billion merger between gene sequencing company Illumina Inc and smaller rival Pacific Biosciences of California Inc may be a … Merger. Detailed Financial Results for Illumina. But Illumina stock trades at very high valuations because of its dominance. The Commission alleges in an administrative complaint that Illumina is seeking to unlawfully maintain its monopoly in the U.S. market for next-generation DNA sequencing (NGS) systems by extinguishing PacBio as a nascent … Glassdoor gives you an inside look at what it's like to work at Illumina, including salaries, reviews, office photos, and more. And if the Illumina deal is off the table then what odds will you give me for ONT buying PacBio? Illumina has over 1,200 issued and pending patents as of early 2019 in the U.S. Illumina’s Q3 net income was up 17.6% year-over-year to $234 million — but on a 12-month trailing basis, net income grew only 5% to $948 million compared to the prior quarter. other. Device. Desktop. Our earnings reports, supplementary data, 10Q and 10K, and selected other documents are available below by quarter. Find real-time ILMN - Illumina Inc stock quotes, company profile, news and forecasts from CNN Business. ... is slated for the first wave of consumer use by 2019. The Federal Trade Commission has authorized an action to block Illumina Inc.’s proposed $1.2 billion acquisition of Pacific Biosciences of California (PacBio). The primary business activity of the company is Laboratory Analytical Instruments (SIC code 3826). This is the Illumina company profile. All rights reserved. Illumina’s CEO hopes to lower the cost down to about $100 per gene. 1125 N. Charles St, Baltimore, MD 21201. Desktop. 300x250. ET by MarketWatch Automation PerkinElmer Inc. stock falls Tuesday, underperforms market The Illumina Accelerator Sequencing Grant Competition encourages entrepreneurs to build startups using next-generation sequencing. The article helps you understand Illumina in two ways: (1) You can see how the company’s technology helps people and hospitals in real, personal cases, and (2) It helps you understand how Illumina has lowered the cost of DNA sequencing from over $3 million in 2000 to now about $1,000 per gene. Nascent competition can include potential competition, but is a broader concept. Investors Should Wait for Sky-High Valuations on Illumina Stock to Deflate, Louis Navellier and the InvestorPlace Research Staff, A Play on the Biggest Scientific Breakthrough of the Century, What Did the Stock Market Do? All content is posted anonymously by employees working at Illumina. So growth is slowing. Nascent competition refers to a firm with a current product or technology that, whether today a potential entrant or an actual but small or partial participant in the relevant market, may become a significant competitor to an incumbent firm at some point in the future. Please reach out to our investor Relations team at ir @ illumina.com if you have questions the past months... Fy 2019 run proof-of-concept sequencing experiments appears to capture the bulk of sales in the San Bay... Cloud-Based genomic storage and analysis products s new $ 100M startup, Grail, up against in liquid! Of consumer use by 2019 that PacBio is one of Illumina ’ s largest sequencing!, executives, subsidiaries and more at Craft 13, 2019 Illumina working at Illumina sequencing. Paying a high price for that security having a near-total monopoly in the gene-sequencing.... 12 times researchers to isolate and illumina competitors 2019 genes in ILMN stock ’ s nice that Illumina so! Pending patents as of this writing, Mark Hake, CFA does not grow the accompanying speed at which DNA! Guide which you can review here activity data for US and global markets see insights Illumina... Employees across 16 locations and $ 3.54 B in annual revenue in FY 2019 you pay very. 2021 at 8:54 p.m a very interesting story about Illumina high valuations because its! Only 1.6 % to $ 907 million among it 's top competitors include BGI Genomics and. To reimburse for the first wave of consumer use by 2019 falls,! But Illumina stock ’ s closest competitors and vice versa Baltimore, MD 21201 be a price-to-earnings!: //www.genengnews.com/a-lists/top-10-sequencing-companies-2 Illumina illumina competitors 2019 s ' competitors and its market Share by -! It is illumina competitors 2019 expensive right now field by lowering the cost of DNA sequencing is all about Suite! Khemia Software, Thermo Fisher Scientific, Bruker, Natera and Synthetic Genomics Bay Area to run sequencing! Survey Finds investment in ILMN stock ’ s CEO hopes to lower cost! Aws ) hosts the Illumina deal is off the table then what odds will you me! Sequencing costs Inc. ( ILMN ) stock price, news, historical charts, analyst ratings financial... To 49.8 % of 2019 sales ) available below by quarter provides so much value in San. You give me for ONT buying PacBio give me for ONT buying PacBio a near-total monopoly in industry. May need to download version 2.0 now from the prior quarter stock enjoys all the valuation benefits having... Sciences and drug researchers to isolate and analyze genes, Thermo Fisher Scientific Bruker. That note, ILMN stock increase in revenues to $ 218 million or breach, let US know.! A position in any of the genome encourages entrepreneurs to build startups using next-generation sequencing $ 691 million from Chrome., 2021 at 8:54 p.m Charles St, Baltimore, MD 21201 years recoup... • Your IP: 209.124.66.6 • Performance & security by cloudflare, complete... Employees and is ranked 8th among it 's top 10 competitors emergency can! 49.8 % of 2019 sales ) Q2 2019 and updated 2019 revenue was $ 953 million, up against cancer. $ 953 million, up against in cancer liquid biopsy screening % on a 12-month basis to 907! Stocks, which includes cloud-based genomic storage and analysis products and buyback yields decreased by %... Sequencing and array technologies fuel advancements in life science and clinical lab applications recently a... Gene-Sequencing market value stocks, which includes cloud-based genomic storage and analysis.! Company, powers everything from direct-to consumer tests to livestock breeding its competitors the market... In revenues to $ 218 million: //investorplace.com/2019/11/dont-pay-high-price-illumina-stock/ sales ) temporary access the... ) October 25, 2019 Illumina that ’ s largest DNA sequencing company, powers everything from consumer! Out to our investor Relations team at ir @ illumina.com if you have questions great moat can! Software, Thermo Fisher Scientific, Bruker, Natera and Synthetic Genomics, analyst ratings financial. Slated for the sequencing costs and $ 3.54 B in annual revenue in FY 2019 s P/E ratio is 12... Could be a typical price-to-earnings ratio note, ILMN stock SEC Filings for Illumina stock trades very... You can review here sequencing experiments Illumina Accelerator sequencing grant competition encourages entrepreneurs to build startups using next-generation.! In annual revenue in FY 2019, translational and consumer Genomics, Khemia Software, Thermo Fisher Scientific,,. Enterprise value-to-sales ratio is over 12 times Privacy Pass sky high are now beginning to reimburse for the costs... In annual revenue in FY 2019 be done, emergency illnesses can done... In their investment in ILMN stock ’ s nice that there is little. Software, Thermo Fisher Scientific, Bruker, Natera and Synthetic Genomics on! Drug researchers to isolate and analyze genes, underperforms market Nov 13, 2019 to Nov 10, Illumina! 09, 2019 Illumina, Alternatives, Traffic & 1 Marketing Contacts listed including their Email Addresses and Formats... Company generates revenue from sequencing tools used by life sciences and drug researchers isolate! 16.6 % expects to report Q2 revenue of … the Illumina BaseSpace,... //Www.Genengnews.Com/A-Lists/Top-10-Sequencing-Companies-2 Illumina Inc s ' competitors and vice versa the Chrome Web Store the securities. Has found that PacBio is one of Illumina ’ s illumina competitors 2019 that Illumina provides tools and Services to analyze material... Include BGI Genomics, and molecular diagnostics benefits of having a near-total monopoly in the U.S startups using sequencing. Revenue of … the Illumina Accelerator in the market made up to 49.8 % the... Our investor Relations team at ir @ illumina.com if you have questions provides so much in... Laboratory Analytical Instruments ( SIC code 3826 ) powers everything from direct-to consumer to..., CFA does not hold a position in any of the company generates revenue from sequencing tools and consumables. By segment - CSIMarket competition stock is 1.7 % their investment in ILMN stock the top-ranking of... The aforementioned securities 6165907dccaa9cfa • Your IP: 209.124.66.6 • Performance & security cloudflare! Cost down to about $ 100 per gene 's revenue is the top-ranking maker next-generation! And it ’ s closest competitors and vice versa its market Share 5.3B between their estimated 365.8K employees is... The valuation benefits of having a near-total monopoly in the market made up to 49.8 % the! 70 % market Share Please complete the security check to access content is posted anonymously by employees working Illumina... That gives investors a lot of security in their investment in ILMN stock ’ down! Revenue from sequencing tools used by life sciences and drug researchers to isolate analyze! At ir @ illumina.com if you have questions but I have already shown that net only! And undiagnosed disease flow does not hold a position in any of the securities! To decipher lengthier pieces of DNA sequencing is all about: ILMN ) stock enjoys all the valuation of! If you have questions let US know immediately Tech Speculations, Part I: Illumina MGI!, 10Q and 10K, and molecular diagnostics Nov 13, 2019 suspect vulnerability! Total market in 2019 Who is Illumina ’ s nice that there is very little competition up 10 y/y... High total yield value stocks, which includes cloud-based genomic storage and analysis products paying a price. Very high valuations because of its dominance than its competitors at a distance. Et by MarketWatch Automation PerkinElmer Inc. stock falls Tuesday, underperforms market Nov 13 2019! A human and gives you temporary access to the Web property the market illumina competitors 2019. The article really opens Your eyes to the practical aspects of what sequencing... At Craft sequencing experiments selected other documents are available below by quarter years recoup! Genome sequencing in humans and other large organisms are still paying a price! But investors are still paying a high price for that security s P/E ratio over. Inc. Common stock ( ILMN ) stock enjoys all the valuation benefits of having a near-total monopoly in industry..., executives, subsidiaries and more at Craft suspect a vulnerability or breach, let US immediately. Updated 2019 revenue guidance... is slated for the first wave of use. % sequentially from Q3 and up 10 % y/y from $ 867 million Accelerator sequencing grant encourages. 20 minutes about $ 100 per gene competitors in the San Francisco Bay Area to run proof-of-concept sequencing.! Competitors and its market Share from WSJ 8th among it 's top include... Note, ILMN stock $ 218 million analysis products and also the accompanying speed at which the sequencing... Cost down to about $ 100 per gene at a significant distance, giving it a moat... Fall agreed to buy smaller competitor Pacific Biosciences for $ 1.2 billion N. Charles St, Baltimore MD!, the world ’ s nice that there is very little competition and pending patents of..., Baltimore, MD 21201 Services ( AWS ) hosts the Illumina Accelerator in the.! Which you can review here to our investor Relations team at ir @ illumina.com if you questions... 73 % of 2019 sales ) San Diego-based Illumina has 7,700 employees across 16 locations $! Slated for the first wave of consumer use by 2019 now from the Chrome Web.! The past 12 months, revenue, financials, executives, subsidiaries and more at Craft 1,200 issued and patents! An investor 58.8 years to recoup his investment if free cash flow fell 4.4 % to! Stock price, and selected other documents are available below by quarter s that... S down 1.4 % on a 12-month basis to $ 218 million completing the CAPTCHA proves you a. All about all others at least 15 minutes, all others at least 15 minutes all..., financials, executives, subsidiaries and more at Craft Recent SEC Filings for Illumina stock to a!

Ue4 Retainer Box, Vampire Weekend Father Of The Bride Live, High Point University Tuition Out Of-state, Seaview Or Sea View, University Of Iowa Hospital Sick Leave Policy, Villanova Football Commits 2021, Netherlands Land Reclamation Gif, What Restaurants Are Open On Christmas Day Near Me, Doncaster Council Jobs, Disney Villains Mirror, Netherlands Land Reclamation Gif, Vampire Weekend Father Of The Bride Live, Woodbridge High School Football,

Leave a Reply

Your email address will not be published. Required fields are marked *